Missense mutations in copper-zinc superoxide dismutase (SOD1) are linked to autosomal-dominant, adult-onset, familial amyotrophic lateral sclerosis (FALS). The principal investigators ofthis application plan a concerted,synergistic approach to determine how these SOD1 mutationsrelate to ALS. Dr. J.S. Valentine's laboratory has a long track record in the study of SOD1metallobiochemistry. Dr. P.J. Hart's laboratory has over 10 years experience in 3-D structure andfunction studies of normal and pathogenic SOD1. Dr. D.R. Borchelt has an established track recordin using transgenic mice to study mechanisms of SOD1-linked FALS. Together, we will use a three-pronged approach to dissecting the toxic mechanism(s) of mutant SOD1 - chemistry (Project 1),3-D structure and solution biophysical properties (Project 2), and disease-specific function (Project 3).To support these projects, we will have a Core that provides analytical support in the form ofproteomics, mass spectrometry, and ICP-MS metal analysis. Our general approach is tocharacterize SOD1 proteins encoding novel mutations that target a particular chemical or structuralfeature of the protein. After thorough in vitro characterization, we will examine, in vivo, the ability ofthese novel SOD1 proteins to cause motor neuron disease. The Project goals are to: 1) understandthe role of oxidative chemistry in both direct and indirect modes of toxicity to motor neurons; 2)understand the consequences of oxidative damage to SOD1 on its structure and its solutionproperties; 3) determine the structural elements in SOD1 that predispose it to produce non-nativehomo- (or hetero-) polymeric interactions, and to understand their role in toxicity to motor neurons;and 4) understand the causes and consequences of mutant SOD aggregation by characterizing theSOD1 protein that is found within these aggregates as well as by characterizing other proteins thatmay be contained within these structures. Through our combined efforts we will be able to definestructure and disease-function relationships at an unprecedented level.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Program Projects (P01)
Project #
5P01NS049134-04
Application #
7469337
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Program Officer
Refolo, Lorenzo
Project Start
2005-08-11
Project End
2010-05-30
Budget Start
2008-05-31
Budget End
2009-05-30
Support Year
4
Fiscal Year
2008
Total Cost
$1,154,270
Indirect Cost
Name
University of California Los Angeles
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Sheng, Yuewei; Capri, Joseph; Waring, Alan et al. (2018) Exposure of Solvent-Inaccessible Regions in the Amyloidogenic Protein Human SOD1 Determined by Hydroxyl Radical Footprinting. J Am Soc Mass Spectrom :
Ayers, Jacob I; McMahon, Benjamin; Gill, Sabrina et al. (2017) Relationship between mutant Cu/Zn superoxide dismutase 1 maturation and inclusion formation in cell models. J Neurochem 140:140-150
Xu, Guilian; Fromholt, Susan; Ayers, Jacob I et al. (2015) Substantially elevating the levels of ?B-crystallin in spinal motor neurons of mutant SOD1 mice does not significantly delay paralysis or attenuate mutant protein aggregation. J Neurochem 133:452-64
Saelices, Lorena; Johnson, Lisa M; Liang, Wilson Y et al. (2015) Uncovering the Mechanism of Aggregation of Human Transthyretin. J Biol Chem 290:28932-43
Gelfand, Paul; Smith, Randy J; Stavitski, Eli et al. (2015) Characterization of Protein Structural Changes in Living Cells Using Time-Lapsed FTIR Imaging. Anal Chem 87:6025-31
Chattopadhyay, Madhuri; Nwadibia, Ekeoma; Strong, Cynthia D et al. (2015) The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation. J Biol Chem 290:30624-36
Xu, Guilian; Ayers, Jacob I; Roberts, Brittany L et al. (2015) Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice. Hum Mol Genet 24:1019-35
Ayers, Jacob; Lelie, Herman; Workman, Aron et al. (2014) Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease. J Neurochem 128:305-14
Ivanova, Magdalena I; Sievers, Stuart A; Guenther, Elizabeth L et al. (2014) Aggregation-triggering segments of SOD1 fibril formation support a common pathway for familial and sporadic ALS. Proc Natl Acad Sci U S A 111:197-201
Bourassa, Megan W; Brown, Hilda H; Borchelt, David R et al. (2014) Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS. Front Aging Neurosci 6:110

Showing the most recent 10 out of 56 publications